tirzepatide care credit Compounded Tirzepatide May Be More Cost-Effective

Semaglutide remains the proven standard of care with an unmatched evidence base and cardiovascular benefit

Appetite Management One of the primary benefits of GLP-1 medications is appetite regulation

For RFS, the survival probabilities at five and 10 years were 95% and 90.9% with GLP-1RAs and 93.8% and 89.9% with SGLT2 inhibitors, respectively

JAMA 2017;318:146070.ArticlePubMedPMC 21

Weeks 10-12 (first 3 weeks post-medication) The medication is clearing your system

Jen de Simone says, "People are microdosing so they get the anti-inflammatory effects without significant weight loss." David Kellner, MD: I would say again, at this time there is no robust clinical evidence demonstrating that microdosing GLP-1-based therapies provides anti-inflammatory benefit separate from weight loss